EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
22,037,221
Total 13F shares
3,845,028
Share change
+260,143
Total reported value
$97,663,000
Price per share
$25.40
Number of holders
36
Value change
+$14,413,392
Number of buys
30
Number of sells
19

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q4 2019

As of 31 Dec 2019, EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,845,028 shares. The largest 10 holders included RTW INVESTMENTS, LP, FARALLON CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, VICTORY CAPITAL MANAGEMENT INC, WASATCH ADVISORS INC, NEXT CENTURY GROWTH INVESTORS LLC, VANGUARD GROUP INC, CALAMOS ADVISORS LLC, BlackRock Inc., and Russell Investments Group, Ltd.. This page lists 36 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.